Connect with us

Hi, what are you looking for?

News

Surgeon General Blames Lack of Marijuana Research on Schedule 1 Status

Surgeon General Jerome Adams hasn’t backed down from his support for expanding medical cannabis research.

Surgeon General Blames Lack of Marijuana Research on Schedule 1 Status
U.S. Public Health Service/ Wikimedia Commons

At a national summit on police efforts to address the United States’ opioid epidemic, U.S. Surgeon General Jerome Adams spoke about the need for further scientific and medical research on cannabis. In response to a question about the U.S. Controlled Substances Act (CSA), Adams called for a review of the way the government schedules different medications, including marijuana. The CSA lists cannabis as a Schedule I substance, a classification reserved for drugs deemed the most dangerous, with no accepted medical use and high abuse potential. The extraordinary difficulty and cost scientists and doctors face if they try to study cannabis is a major consequence of that classification. In the U.S., no drug is both as common yet as under-researched as marijuana. And Surgeon General Adams blames the lack of research on the plant’s Schedule I status.

U.S. Surgeon General Renews Support for Rescheduling Medical Cannabis

Last Thursday’s statements at the Police Assisted Addiction Recovery Initiative conference in Massachusetts weren’t the first time Surgeon General Jerome Adams has spoken favorably about reclassifying medical cannabis. In a public speech last December at the National Black Caucus of State Legislators’ annual conference, Adams said he felt medical marijuana “should be like any other drug.”

During the speech, Adams went on to call for allowing the FDA to vet and study medical cannabis. Last December, the FDA had not yet approved the cannabis-derived epilepsy medication Epidiolex. But it had approved cannabidiol oil and other CBD derivatives. The FDA has also authorized a handful of studies, including one investigating the use of cannabis to treat PTSD in veterans.

Adams’ comments last week echo his speech from a year ago. As Surgeon General, he still doesn’t condone adult, “recreational” cannabis use. And he remains adamantly opposed to smoking cannabis, even for medical reasons. Nevertheless, Adams is committed to basing policy decisions on science, not the threadbare prejudices that have hampered federal drug reform for decades. Throughout his career, for example, Adams has supported a number of evidence-based harm reduction approaches to a range of public health issues, from opioids to HIV/AIDS. However, Adams remains skeptical about cannabis’ potential as an opioid exit drug or opioid replacement.

Surgeon General Needs to Apply Pressure to Justice Department on Rescheduling MMJ

Adams’ position on medical cannabis stands in sharp contrast to that of former Attorney General Jeff Sessions. And with Sessions out of office, there’s an opportunity for the Surgeon General to put some pressure on the Justice Department regarding rescheduling medical cannabis. He’d have the support of members of Congress, where a bi-partisan consensus on the need for amending the CSA continues gaining momentum. It would be possible to create a separate research designation for cannabis, opening up avenues to research that have remained blocked by federal prohibition.

“Just as we need to look at criminal justice laws, rules and regulations, we need to look at health laws, rules and regulations, and that includes the scheduling system,” Adams said. Then again, advocates have a strong case that the time for looking is over and what’s needed now is concrete action.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement

HT Newsletter

Subscribe for exclusive access to deals, free giveaways and more!

Thank you for subscribing.

Something went wrong.

Advertisement

You May Also Like

Science

Research Director Ziva Cooper will use the funds to research terpenes and pain management.

Politics

Prohibitionists around the world have long used rhetoric to associate the plant with violence and depravity.

Health

One second-hand toke could prove to be one too many.

News

Yale University School of Medicine has teamed up with a Connecticut-based producer of medical marijuana products for an innovative new health study.

News

The new partnership could make it much easier for researchers to source cannabis.

News

The project will be subsidized by a $3.5 million grant from the National Institute on Drug Abuse, which is a branch of the National...

News

The Unites States government is spending $3 million to research the health benefits of cannabis, yet it remains illegal on the federal level.

News

The Expanding Cannabis Research and Information Act aims to take a closer look at the health benefits of marijuana.

Do NOT follow this link or you will be banned from the site!